Roelof F. Van Leeuwen
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma.
Journal: Clinical pharmacology and therapeutics
Published: July 04, 2025
Errata: Environmental Impact Assessment of Intravenous Versus Subcutaneous Monoclonal Antibodies: A Carbon Footprint Analysis.
Journal: JCO oncology practice
Published: June 04, 2025
Capacity and cost benefits of subcutaneous versus intravenous pertuzumab/trastuzumab: The EASE-SC study.
Journal: Breast (Edinburgh, Scotland)
Published: May 06, 2025
Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach.
Journal: Applied health economics and health policy
Published: November 28, 2024
Why We Should, and How We Can, Reduce the Climate Toxicity of Cancer Care.
Journal: JCO oncology practice
Published: November 01, 2024
Bioequivalence of alternative pembrolizumab dosing regimens: current practice and future perspectives.
Journal: Cancer communications (London, England)
Published: September 25, 2024
Climate Therapy: Sustainability Solutions for Breast Cancer Care in the Anthropocene Era.
Journal: Clinical breast cancer
Published: July 03, 2024
Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 18, 2024
Effect of Switching the Histamine-1 Receptor Antagonist Clemastine to Cetirizine in Paclitaxel Premedication Regimens: The H1-Switch Study.
Journal: JCO oncology practice
Published: June 07, 2024
The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study.
Journal: Clinical pharmacokinetics
Published: May 30, 2024
Effect of alternative dosing strategies of pembrolizumab and nivolumab on health-care emissions in the Netherlands: a carbon footprint analysis.
Journal: The Lancet. Planetary health
Published: April 19, 2024
Last Updated: 09/26/2026